Rights and permissions
About this article
Cite this article
Benzodiazepines remain `mainstay' of treatment for anxiety disorders. Pharmacoecon. Outcomes News 250, 6 (2000). https://doi.org/10.1007/BF03266855
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03266855